Small Pharma, Big Studies.
Xerimis is uniquely positioned to service the specific needs of small to mid-sized pharmaceutical companies. We know that the task of a modern day clinical packaging organization demands excellence in two key areas: an industry-leading knowledge of the landscape and its complexities along with a tireless dedication to client needs. At Xerimis, we understand the unique demands of your project, and we're here, alongside you, every step of the way.
Agile Ability with Global Reach.
The benefits of an international player with the agility of something much more personal
Insights & News
On Saturday, March 21st, the Governor of New Jersey issued an Executive Order No. 107 requiring all Non-Essential Retail Businesses to close. Xerimis is not forcedto close our business since Xerimis is part of the pharmaceutical supply chain responsible for providing medicines to patients, and as such is considered in the category defined as Healthcare/Life Sustaining businesses.
As the clinical supply industry evolves, so does its vernacular. Small molecules are making way for large ones, resulting in genetic therapies. We no longer work in ambient conditions; today, controlled room temperature best describes the handling process. Even the term sponsor company itself evolved from the fact that companies other than R&D pharmaceuticals are running trials.